Author:
Zheltikova Tat'yana Mikhaylovna,Hrabina M,Antropova A B,Zheltikova T M,Hrabina M,Antropova A B
Abstract
The article deals with the problems of standardization of allergen vaccines for ASIT performing. At present time there are no uniform requirements, criteria and methods which allow to standardize these preparations. There upon information about preparation or cultivation of raw materials, about methods used for allergen vaccines biological activity evaluation, and about units for this activity expression is very important for choosing the preparation for ASIT. The information about major clinically significant allergens concentration is necessary because ASIT both effectiveness and safety depend on it. Phostal and Staloral are examples of these thoroughly characterized and standardized allergen vaccines.
Reference24 articles.
1. WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Editors Bousquet J., Lockey R.F., Malling H.J. Allergy. 1998, v. 53, suppl. 44, 42 p.
2. Esch R.E. Evaluation of allergen vaccine potency. Curr. Allergy Asthma Rep. 2006, v. 6, No. 5, p. 402-406.
3. Slater J.E. Characterization of allergen extracts. Dev. Biol. 2005, v. 122, p. 145-152.
4. Slater J.E. Standardized allergen vaccines in the United States. Clin. Allergy Immunol. 2008, v. 21, p. 273-281.
5. Lorenz A.R., Lüttkopf D., Seitz R., Vieths S. The Regulatory System in Europe with Special Emphasis on Allergen Products. Int. Arch. Allergy Immunol. 2008, v. 147, p. 263-275.